Paul Labrousse

Paul Labrousse is the Translational Genomics Associate Director at AstraZeneca, where they have been a Senior Scientist since 2018. With over 12 years of molecular assay development experience in the IVD industry and more than 15 years in R&D laboratories, Paul has led various projects including 510(k) cleared assays and developed new molecular programs. Their past roles include positions at Sekisui Diagnostics, LLC, MolecularMD, and Intelligent MDx, where they contributed to the development and validation of numerous diagnostic assays. Paul holds a Master of Science degree in Biotechnology from Worcester State University, earned in 2007.